Skip to content Skip to navigation
See our Campus Ready site for the most up to date information about instruction.Campus ReadyCOVID Help

Kayla Williams (CAMP)

Assessing IgM and IgG Antibody Levels Across Autoimmune Disease Progression

Kayla R. Williams, Katrina Hoyer (PhD), Genevieve Mullins

Autoimmune disease is a condition in which the immune system mistakenly attacks the body. Normally the body launches a response to bacteria and viruses by sending out immune cells to identify and attack the pathogen. In the case of autoimmune disease these cells identify a part of the body as foreign. The body will then release proteins called auto-antibodies that will attack healthy cells. Systemic autoimmune mice, MRL-LPR are known for their induction of auto-antibody mediated immune responses. These mice can be used to track antibody class switching in response to the differentiation of specialized T cell subsets (CD4+ T follicular helpers (Tfh) and CD8+ T follicular cytotoxic (Tfc) cells) that help drive antibody responses. This project aims to track total IgM and IgG antibody levels across time using enzyme-linked immunosorbent assays (ELISA).Using these antibody levels and previously acquired immune cell data, we aim to correlate immune cell changes (particularly of CD4+ tfh and CD8+ tfc) with antibody levels across autoimmune disease progression. We believe antibody levels will increase as CD4+ Tfh arise further leading us to speculate that antibody levels will also increase as CD8+ Tfc arise. This will help to aid the general understanding of CD8+ Tfc impact on autoimmune disease.

 

 

Email Scholar - Provide Feedback - Return to Showcase Gallery